Overview

Phase 2 Study of TD-9855 to Treat Fibromyalgia

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study study is to determine whether TD-9855 is effective in treating patients with fibromyalgia.
Phase:
Phase 2
Details
Lead Sponsor:
Theravance Biopharma
Theravance Biopharma R & D, Inc.